International Immunology Advance Access originally published online on May 21, 2009
International Immunology 2009 21(6):705-713; doi:10.1093/intimm/dxp039
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prediction of HLA-DQ8 β cell peptidome using a computational program and its relationship to autoreactive T cells
1 Division of Immunology, Department of Pathology and Immunology
2 Computational Biology Program, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St Louis, MO 63110, USA
Correspondence to: E. R. Unanue; E-mail: unanue{at}pathbox.wustl.edu
The goal was to identify HLA-DQ8-bound β cell epitopes important in the T cell response in autoimmune diabetes. We first identified HLA-DQ8 (DQA1*0301/DQB1*0302) β cell epitopes using a computational approach and then related their identification to CD4 T cell responses. The computational program (TEA-DQ8) was adapted from one previously developed for identifying peptides bound to the I-Ag7 molecule and based on a library of naturally processed peptides bound to HLA-DQ8 molecules of antigen-presenting cells. We then examined experimentally the response of NOD.DQ8 mice immunized with peptides derived from the Zinc transporter 8 protein. Log-of-odds scores on peptides were experimentally validated as an indicator of peptide binding to HLA-DQ8 molecules. We also examined previously published data on diabetic autoantigens, including glutamic acid decarboxylase-65, insulin and insulinoma-associated antigen-2, all tested in NOD.DQ8 transgenic mice. In all examples, many peptides identified with a favorable binding motif generated an autoimmune T cell response, but importantly many did not. Moreover, some peptides with weak-binding motifs were immunogenic. These results indicate the benefits and limitations in predicting autoimmune T cell responses strictly from MHC-binding data. TEA-DQ8 performed significantly better than other prediction programs
Keywords: HLA-DQ8, MHC class II molecules, T cell epitope prediction, type I diabetes mellitus
Transmitting editor: M. Feldmann
Received 7 October 2008, accepted 6 April 2009.